Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10844517rdf:typepubmed:Citationlld:pubmed
pubmed-article:10844517lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:10844517lifeskim:mentionsumls-concept:C0007634lld:lifeskim
pubmed-article:10844517lifeskim:mentionsumls-concept:C0020517lld:lifeskim
pubmed-article:10844517lifeskim:mentionsumls-concept:C0597357lld:lifeskim
pubmed-article:10844517lifeskim:mentionsumls-concept:C0417744lld:lifeskim
pubmed-article:10844517lifeskim:mentionsumls-concept:C0017262lld:lifeskim
pubmed-article:10844517lifeskim:mentionsumls-concept:C2709199lld:lifeskim
pubmed-article:10844517lifeskim:mentionsumls-concept:C0021469lld:lifeskim
pubmed-article:10844517lifeskim:mentionsumls-concept:C2911684lld:lifeskim
pubmed-article:10844517lifeskim:mentionsumls-concept:C0185117lld:lifeskim
pubmed-article:10844517pubmed:issue3lld:pubmed
pubmed-article:10844517pubmed:dateCreated2000-6-27lld:pubmed
pubmed-article:10844517pubmed:abstractTextRecent studies have revealed the existence of a distinct type of NK cell leukaemia of the juvenile type, which presents with hypersensitivity to mosquito bites (HMB) as an essential clinical manifestation and is infected with clonal Epstein-Barr virus (EBV). This disorder is thus called HMB-EBV-NK disease and has been reported in Orientals, mostly from Japan. We investigated the profile of cytokine production and the expression of both types of NK inhibitory receptors, i.e. CD94 lectin-like dimers and killer-cell immunoglobulin-like receptors, in NK leukaemic cells from three patients with HMB-EBV-NK disease. It was found that freshly isolated NK leukaemic cells expressed mRNA for interferon-gamma (IFN-gamma) and additionally produced IL-10 upon stimulation with IL-2, indicating that the NK cells were of NK1 type. More than 98% of NK cells from the patients bore CD94 at a higher level than did normal NK cells, whereas p70 or NKAT2, belonging to immunoglobulin-like receptor, was not expressed in those NK cells. Freshly isolated leukaemic NK cells transcribed mRNA for CD94-associated molecule NKG2C at an abnormally high level, and upon stimulation with IL-2 and/or IL-12 they expressed NKG2A as well. The disordered expression of these inhibitory receptors not only provides some insights into the pathogenesis of HMB-EBV-NK disease but also can be used as phenotypic markers for the diagnosis of this type of NK cell leukaemia.lld:pubmed
pubmed-article:10844517pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10844517pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10844517pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10844517pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10844517pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10844517pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10844517pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10844517pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10844517pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10844517pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10844517pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10844517pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10844517pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10844517pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10844517pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10844517pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10844517pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10844517pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10844517pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10844517pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10844517pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10844517pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10844517pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10844517pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10844517pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10844517pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10844517pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10844517pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10844517pubmed:languageenglld:pubmed
pubmed-article:10844517pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10844517pubmed:citationSubsetIMlld:pubmed
pubmed-article:10844517pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10844517pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10844517pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10844517pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10844517pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10844517pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10844517pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10844517pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10844517pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10844517pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10844517pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10844517pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10844517pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10844517pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10844517pubmed:statusMEDLINElld:pubmed
pubmed-article:10844517pubmed:monthJunlld:pubmed
pubmed-article:10844517pubmed:issn0009-9104lld:pubmed
pubmed-article:10844517pubmed:authorpubmed-author:TakigawaMMlld:pubmed
pubmed-article:10844517pubmed:authorpubmed-author:IshiharaSSlld:pubmed
pubmed-article:10844517pubmed:authorpubmed-author:TagawaSSlld:pubmed
pubmed-article:10844517pubmed:authorpubmed-author:TokuraYYlld:pubmed
pubmed-article:10844517pubmed:authorpubmed-author:SeoNNlld:pubmed
pubmed-article:10844517pubmed:authorpubmed-author:TakeokaYYlld:pubmed
pubmed-article:10844517pubmed:issnTypePrintlld:pubmed
pubmed-article:10844517pubmed:volume120lld:pubmed
pubmed-article:10844517pubmed:ownerNLMlld:pubmed
pubmed-article:10844517pubmed:authorsCompleteYlld:pubmed
pubmed-article:10844517pubmed:pagination413-9lld:pubmed
pubmed-article:10844517pubmed:dateRevised2009-11-18lld:pubmed
pubmed-article:10844517pubmed:meshHeadingpubmed-meshheading:10844517...lld:pubmed
pubmed-article:10844517pubmed:meshHeadingpubmed-meshheading:10844517...lld:pubmed
pubmed-article:10844517pubmed:meshHeadingpubmed-meshheading:10844517...lld:pubmed
pubmed-article:10844517pubmed:meshHeadingpubmed-meshheading:10844517...lld:pubmed
pubmed-article:10844517pubmed:meshHeadingpubmed-meshheading:10844517...lld:pubmed
pubmed-article:10844517pubmed:meshHeadingpubmed-meshheading:10844517...lld:pubmed
pubmed-article:10844517pubmed:meshHeadingpubmed-meshheading:10844517...lld:pubmed
pubmed-article:10844517pubmed:meshHeadingpubmed-meshheading:10844517...lld:pubmed
pubmed-article:10844517pubmed:meshHeadingpubmed-meshheading:10844517...lld:pubmed
pubmed-article:10844517pubmed:meshHeadingpubmed-meshheading:10844517...lld:pubmed
pubmed-article:10844517pubmed:meshHeadingpubmed-meshheading:10844517...lld:pubmed
pubmed-article:10844517pubmed:meshHeadingpubmed-meshheading:10844517...lld:pubmed
pubmed-article:10844517pubmed:meshHeadingpubmed-meshheading:10844517...lld:pubmed
pubmed-article:10844517pubmed:meshHeadingpubmed-meshheading:10844517...lld:pubmed
pubmed-article:10844517pubmed:meshHeadingpubmed-meshheading:10844517...lld:pubmed
pubmed-article:10844517pubmed:meshHeadingpubmed-meshheading:10844517...lld:pubmed
pubmed-article:10844517pubmed:meshHeadingpubmed-meshheading:10844517...lld:pubmed
pubmed-article:10844517pubmed:meshHeadingpubmed-meshheading:10844517...lld:pubmed
pubmed-article:10844517pubmed:meshHeadingpubmed-meshheading:10844517...lld:pubmed
pubmed-article:10844517pubmed:meshHeadingpubmed-meshheading:10844517...lld:pubmed
pubmed-article:10844517pubmed:meshHeadingpubmed-meshheading:10844517...lld:pubmed
pubmed-article:10844517pubmed:meshHeadingpubmed-meshheading:10844517...lld:pubmed
pubmed-article:10844517pubmed:meshHeadingpubmed-meshheading:10844517...lld:pubmed
pubmed-article:10844517pubmed:year2000lld:pubmed
pubmed-article:10844517pubmed:articleTitleDisordered expression of inhibitory receptors on the NK1-type natural killer (NK) leukaemic cells from patients with hypersensitivity to mosquito bites.lld:pubmed
pubmed-article:10844517pubmed:affiliationDepartment of Dermatology, Hamamatsu University School of Medicine, Hamamatsu, Japan. seo445@hama-med.ac.jplld:pubmed
More...